This is a news story, published by TechCrunch, that relates primarily to Joe Betts-LaCroix news.
For more Joe Betts-LaCroix news, you can click here:
more Joe Betts-LaCroix newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from TechCrunch, you can click here:
more news from TechCrunchOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
OpenAI CEO Sam Altman. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest OpenAI news, other major billionaire news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
biotech startupTechCrunch
•76% Informative
Retro Biosciences wants humans to live 10 years longer than what it calls a healthy human lifespan.
It plans to launch trials for drugs targeting diseases like Alzheimer’s.
CEO Joe Betts-LaCroix wants to move fast by discovering and developing a drug “in the 2020s ”.
VR Score
63
Informative language
53
Neutral language
89
Article tone
formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Affiliate links
no affiliate links